A team led by researchers from Stanford University has developed a multi-omics approach for profiling individuals' immune systems.

Using a combination of proteomic and genomic techniques, the scientists identified nine markers with which they were able to predict patient response to an influenza vaccine with 84 percent accuracy.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.